Altio Decision Intelligence
AI for life sciences.
Altio turns the regulated documents and data you rely on, internal and external, into a longitudinal record that becomes one institutional memory. Built once at the core, that record carries forward as decisions move from safety to clinical, regulatory, quality, and beyond. Every answer traces back to the exact passage that required it, so review is checking the work rather than redoing it.
Is this signal new, or the same one we assessed eighteen months ago under a different name?
Internal
It is the same signal. The pattern flagged this week matches the assessment closed in February 2025, recorded then as “cytokine storm” in the case narratives1, and the committee's rationale is carried forward on the product record2.
Read from
Powered by Altio COG™, patent pending, the obligation engine behind every record.
Our mission
We help people live longer, healthier lives by enabling better, faster decisions.
Our thesis
In regulated science, governance is not the brake on AI adoption: it is the enabler.
The conservatism of pharmacovigilance is rational: you have to prove a system before you trust it. Altio treats that as the design starting point, not an afterthought.
Teams that run on audit-ready infrastructure deploy faster, pass inspection, and earn the confidence of health authorities. That is what the platform is built to do. The same record and the same discipline extend wherever a decision must be traced back to evidence, not just safety.
What it produces
Ask in plain language, read the answer, and open the passage behind every statement.
Evidence assembled across data and documents, with prior assessments surfaced.
See the sessionOne section per agency question, cited to source and dual-signed before release.
See the sessionAssembled from the record, with every figure anchored to the row it came from.
See the sessionDrafted and numbered to the ICH E3 guideline, with tables built from the data.
See the sessionHow it works
Altio sits above the systems you already run. It ingests documents and data across sources, builds the longitudinal record, and produces audit-ready outputs, replacing uncontrolled tooling with traceable, reproducible work.
Each one drawn from the same institutional memory, extending to CTD and regulatory work, then medical affairs and evidence, as modules come online, with PBRER as a natural progression built with a design partner.
Connects to the stores you already run. Intake draws on public data such as FAERS alongside the documents you bring from your safety database, literature, and document management system, and signed deliverables flow downstream to Veeva Vault by API.
How the work is controlled
The same discipline applies whichever deliverable you are working on.
Track record
Outcomes
Team
Direct operating experience in pharmacovigilance, clinical systems, and regulatory technology, and the AI architecture to put it into production.
Founder & CEO
Co-founder & CTO
Senior Medical Advisor
Platform Security Lead
Latest
News · Collaboration
ELIQUENT brings deep pharmacovigilance expertise from years of work inside regulated environments. Altio brings AI built specifically for life sciences. It is early days, and we will share more as the work takes shape.
News · Open Altio
Open Altio is live: twenty years of FDA adverse event reports, cleaned and deduplicated, free to use, with the code and every cleaning rule open on GitHub.
Platform · Security
An automated audit checks our own code, the third-party code we rely on, the running application, our cloud configuration and our AI features. This is what that process does, in plain terms.